Back to Article List

New GM source for infant formula


May 10, 2022

Food Standards Australia New Zealand (FSANZ) announced the approval of Application A1233, that is, FSANZ permitted the sale and use of 2ʹ-fucosyllactose (2′-FL) derived from a new genetically modified Escherichia coli strain as a nutritive substance used in infant formula products (infant formula, follow-on formula, and infant formula products for special dietary use).


For further information (in English), click on the Link



Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox